ON THE MECHANISM OF THE REACTION BETWEEN HUMAN ALPHA ₂-ANTIPLASMIN AND PLASMINWIMAN B; COLLEN D.1979; J. BIOL. CHEM.; USA; DA. 1979; VOL. 254; NO 18; PP. 9291-9297; BIBL. 32 REF.Article

ACTIVATION OF HUMAN GLU-PLASMINOGEN TO GLU-PLASMIN BY UROKINASE IN PRESENCE OF PLASMIN INHIBITORS. STREPTOMYCES LEUPEPTIN AND HUMAN PLASMA ALPHA ₁-ANTITRYPSIN AND ANTITHROMBIN III (PLUS HEPARIN).SUMMARIA L; BOREISHA IG; ARZADON L et al.1977; J. BIOL. CHEM.; U.S.A.; DA. 1977; VOL. 252; NO 11; PP. 3945-3951; BIBL. 34 REF.Article

ON THE SPECIFIC INTERACTION BETWEEN THE LYSINE-BINDING SITES IN PLASMIN AND COMPLEMENTARY SITES IN ALPHA ₂-ANTIPLASMIN AND IN FIBRINOGENWIMAN B; LIJNEN HR; COLLEN D et al.1979; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1979; VOL. 579; NO 1; PP. 142-154; BIBL. 36 REF.Article

DETERMINATION OF ALPHA ₂-PLASMIN INHIBITOR IN BODY FLUIDSMATSUO O; KATO K; MIHARA H et al.1982; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1982; VOL. 27; NO 5; PP. 555-562; BIBL. 19 REF.Article

ALPHA ₂-PLASMIN-INHIBITOR DEFICIENCY (MIYASATO DISEASE)KOIE K; OGATA K; KAMIYA T et al.1978; LANCET; GBR; DA. 1978; NO 8104; PP. 1334-1336; BIBL. 8 REF.Article

STUDIES ON A FORM OF ALPHA ₂-ANTIPLASMIN IN PLASMA WHICH DOES NOT INTERACT WITH THE LYSINE-BINDING SITES IN PLASMINOGENWIMAN B; NILSSON T; CEDERGREN B et al.1982; THROMB. RES.; ISSN 0049-3848; USA; DA. 1982; VOL. 28; NO 2; PP. 193-199; BIBL. 17 REF.Article

INFLUENCE OF DEXTRAN 70 ON THE ACTION OF THE PRIMARY FIBRINOLYSIS INHIBITOR (ALPHA ₂-PLASMIN INHIBITOR).CARLIN G; SALDEEN T.1978; THROMBOSIS RES.; G.B.; DA. 1978; VOL. 12; NO 4; PP. 681-686; BIBL. 10 REF.Article

ON THE REACTION OF PLASMIN OR PLASMIN-STREPTOKINASE COMPLEX WITH APROTININ OR ALPHA ₂-ANTIPLASMINWIMAN B.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 17; NO 1-2; PP. 143-152; BIBL. 18 REF.Article

KINETICS OF THE REACTIONS BETWEEN STREPTOKINASE, PLASMIN AND ALPHA ₂-ANTIPLASMINCEDERHOLM WILLIAMS SA; DE COCK F; LIJNEN HR et al.1979; EUROP. J. BIOCHEM.; DEU; DA. 1979; VOL. 100; NO 1; PP. 125-132; BIBL. 27 REF.Article

Effects of kringles derived from human plasminogen on fibrinolysis in vitroSUGIYAMA, N; IWAMOTO, M; ABIKO, Y et al.Thrombosis research. 1987, Vol 47, Num 4, pp 459-468, issn 0049-3848Article

Cryoenzymology of human plasmin catalysis: comparison of cryosolvents and reactions with nitrophenyl ester and anilide substratesCOLL, R. J; FINK, A. L.Cryobiology (Print). 1987, Vol 24, Num 4, pp 332-344, issn 0011-2240Article

Structure and formation of microplasminHUA-LIN WU; GUEY-YUEH SHI; WOHL, R. C et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 24, pp 8793-8795, issn 0027-8424Article

INFLUENCE OF ALPHA ₂-PLASMIN INHIBITOR ON ADSORPTION OF PLASMINOGEN TO FIBRINAOKI N; SAKATA Y.1980; THROMB. RES.; ISSN 0049-3848; USA; DA. 1980; VOL. 19; NO 1-2; PP. 149-155; BIBL. 11 REF.Article

ETUDE DE LA PLASMINE ET DE SES ENZYMES DANS L'HYDRONEPHROSE EXPERIMENTALEUYAMA T.1975; NISHINIHON J. UROL.; JAP.; DA. 1975; VOL. 37; NO 5; PP. 693-703; ABS. ANGL.; BIBL. 39 REF.Article

DETERMINATION OF PLASMIN-ALPHA ₂ ANTIPLASMIN COMPLEX IN PLASMA SAMPLES BY MEANS OF A RADIOIMMUNOASSAYWIMAN B; JACOBSSON L; ANDERSSON M et al.1983; SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION; ISSN 0036-5513; NOR; DA. 1983; VOL. 43; NO 1; PP. 27-33; BIBL. 21 REF.Article

EFFECTS OF HUMAN GRANULOCYTE ELASTASE ON FIBRINOLYSISNAGAMATSU A; SOEDA S.1981; CHEM. PHARM. BULL.; ISSN 0009-2363; JPN; DA. 1981; VOL. 29; NO 4; PP. 1121-1129; BIBL. 32 REF.Article

CHANGES IN ANTIPLASMIN AND PLASMIN ACTIVITIES DURING EXTREME HEMODILUTION AND OPEN HEART SURGERY IN DOGSAASEN AO; GALLIMORE MJ; LILLEAASEN P et al.1979; EUROP. SURG. RES.; CHE; DA. 1979; VOL. 11; NO 3; PP. 145-153; BIBL. 33 REF.Article

PARTICULARITES DE L'ACTIVATION PAR CONTACT DES SYSTEMES CALLICREINIQUES ET PLASMINIQUES DU SANG DU LAPINKOMISSAROVA NV; GOMAZKOV OA.1976; BJULL. EKSPER. BIOL. MED.; S.S.S.R.; DA. 1976; VOL. 81; NO 4; PP. 390-392; ABS. ANGL.; BIBL. 12 REF.Article

UTILISATION DE LA FIBRINE DE PLASMA NON FRACTIONNE DE BOVINS POUR LE DOSAGE DIFFERENTIEL DES ANTIPLASMINES DANS LE SERUM SANGUINVERZHIKOVSKAYA VR; BYSHEVSKIJ A SH.1973; LAB. DELO; S.S.S.R.; DA. 1973; NO 2; PP. 94-96; BIBL. 6 REF.Serial Issue

Lipoprotein (a) promotes inhibition by α₂-antiplasminEDELBERG, M; PIZZO, S. V.Biochemical journal (London. 1984). 1992, Vol 286, pp 79-84, issn 0264-6021, 1Article

ELECTROCHEMICAL ACTIVITY DETERMINATION OF TRYPSIN-LIKE ENZYMES. VII: PLASMIN AND ANTIPLASMIN IN AQUEOUS SOLUTIONS AND HUMAN PLASMALEBAIL G; NIGRETTO JM; JOZEFOWICZ M et al.1983; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1983; VOL. 30; NO 1; PP. 55-60; BIBL. 9 REF.Article

INTERACTION OF PLASMIN WITH ALPHA ₂-MACROGLOBULIN AND ALPHA ₂-ANTIPLASMIN IN THE PRESENCE AND ABSENCE OF TRANEXAMIC ACIDTAKADA A; TAKADA Y.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 18; NO 1-2; PP. 237-246; BIBL. 23 REF.Article

The plasminogen-plasmin systemHENKIN, J; MARCOTTE, P; HEECHUNG YANG et al.Progress in cardiovascular diseases. 1991, Vol 34, Num 2, pp 135-164, issn 0033-0620Article

Fibrinolytic therapy : biochemical mechanismsROBBINS, K. C.Seminars in thrombosis and hemostasis. 1991, Vol 17, Num 1, pp 1-6, issn 0094-6176Article

Mafenide (sulfamylon^TM) inhibits plasmin fibrinolytic activityWEISDORF, D. J; ALDRIDGE, J. H.Thrombosis and haemostasis. 1988, Vol 59, Num 3, pp 440-444, issn 0340-6245Article